Navigation Links
Big pharma seeks Wisconsin biotech partnerships

Fitchburg, Wis. - Under pressure from expiring patents, generic drugs, and increasing costs of finding and developing new drugs, big pharmaceutical companies are increasingly turning to innovative biotechnology companies to outsource specific scientific development efforts and produce new business opportunities.

At a recent meeting of the ......

Full article >>> br>
Local bioscience firms seek deals

Many biopharmaceutical companies are established on the basis that they will partner with pharmaceutical companies. For instance, Mithridion, Inc., a firm seeking to develop drugs for Alzheimer's disease, aims to develop drug candidates in house, manage Phase I and II clinical trials with the help o......

Full article >>>
'"/>

Source:wistechnology.com By Chris Fleissner 12/05/06


Related biology technology :

1. Development of a sensitive enzyme fragment complementation assay for cyclic adenosine 3, 5 monophosphate and its validation for pharmacological screening at G protein-coupled receptors
2. Germantown drug company hires pharma veteran James Davidson as COO
3. New angel capital centered on GenTel agreement with big pharma
4. Doing the pharmaceutical tango
5. Chinese pharma-biotech dragon rears its head
6. Swiss biotech has quality of its big pharma, watch and chocolate industries
7. Third Wave receives FDA clearance of pharmacogenetic test
8. Line between big pharma, big biotech continues to blur
9. Top 20 big pharmas represent majority of world pharma market
10. Though pharma growth slides, blockbusters reach new record
11. Indian pharma delegation arrives in Chicago as part of multi-city tour
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial ... Cary 5000 and the 6000i models are higher end machines that use the more ... the spectrophotometer’s light beam from the bottom of the cuvette holder. , FireflySci ...
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
(Date:6/23/2016)... 23, 2016  The Biodesign Challenge (BDC), a university ... to harness living systems and biotechnology, announced its winning ... New York City . ... showcased projects at MoMA,s Celeste Bartos Theater during the ... MoMA,s senior curator of architecture and design, and ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology:
(Date:4/15/2016)... CHICAGO , April 15, 2016  A ... companies make more accurate underwriting decisions in a ... offering timely, competitively priced and high-value life insurance ... health screenings. With Force Diagnostics, rapid ... and lifestyle data readings (blood pressure, weight, pulse, ...
(Date:4/14/2016)... AVIV, Israel , April 14, 2016 ... Behavioral Authentication and Malware Detection, today announced the appointment ... already assumed the new role. Goldwerger,s leadership ... BioCatch, on the heels of the deployment of its ... addition, BioCatch,s behavioral biometric technology, which discerns unique cognitive ...
(Date:3/31/2016)...   LegacyXChange, Inc. ... LegacyXChange is excited to release its first ... be launched online site for trading 100% guaranteed authentic ... also provide potential shareholders a sense of the value ... industry that is notorious for fraud. The video is ...
Breaking Biology News(10 mins):